Elevation Oncology, the biotech startup that’s developing cancer therapies based on genetic signature versus tumor origin, has raised $32.5M in Series A funding from investors that include Aisling Capital, Vertex Ventures HC, BVF Partners, Driehaus Capital Management, and Qiming Venture Partners USA. Elevation Oncology was founded by Shawn Leland in 2018.

Talk change with CX leaders on August 11th. Hear from Shark Tank’s Daymond John and Zendesk customers on navigating the ever-evolving consumer landscape.
Join Zendesk and Daymond John in a live virtual event focusing on leading through change, entrepreneurship, and the importance of customer retention in our new, ever-evolving consumer landscape. REGISTER NOW FOR FREE